Second Genome Garners $5,000,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e9bc60fd-3df7-4017-99d2-b0df68917daa&Preview=1 - Date
8/9/2011 - Company Name
Second Genome - Mailing Address
1700 Owens Street 5th Floor San Francisco, CA 94158 - Company Description
Second Genome, a venture-backed Bay Area based life sciences company, is committed to improving the quality of human health through microbiome-based personalized medicine. Founded in 2009 by leading experts in microbial research, molecular diagnostics, and biotechnology R&D, Second Genome is using its proprietary Microbiome Signature Discovery platform to generate novel insights relating the microbiome with a wide range of human health disorders. - Website
http://www.secondgenome.com - Transaction Type
Venture Equity - Transaction Amount
$5,000,000 - Transaction Round
Series A - Proceeds Purposes
Second Genome will use the $5 million investment to further its development of microbiome-based personalized medicine solutions for gastrointestinal diseases and disorders. - M&A Terms
- Venture Investor
Advanced Technology Ventures - Venture Investor
Morgenthaler Ventures - Venture Investor
Wavepoint Ventures - Venture Investor
Seraph Group
